Pneumococcal vaccination and risk of myocardial infarction. - Wikidata - awgldk - TriplyDB

Pneumococcal vaccination and risk of myocardial infarction.

Pneumococcal vaccination and risk of myocardial infarction.

http://www.wikidata.org/entity/Q36909937

about

Vaccines for preventing pneumococcal infection in adults Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis Long-term trends in cardiovascular disease mortality and association with respiratory disease.Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects.Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions.Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes.Drug-induced thrombocytopenia in the critically ill: a case-control study.Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke.Vaccine against arteriosclerosis: an update.Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia.Management of community-acquired pneumonia in older adults.Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study.Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up Pneumococcal pneumonia and the risk of stroke: a population-based follow-up study.Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong Adult immunization: last on the list.The intangible benefits of vaccination - what is the true economic value of vaccination?Acute infections, vaccination and prevention of cardiovascular disease.Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination.Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination.Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies.Does pneumococcal vaccination prevent myocardial infarction and stroke in elderly adults?Immunisation chez l’adulte: Dernière de la liste.Pneumococcal vaccination and myocardial infarction.Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.Workshop on immunizations in older adults: identifying future research agendas.

P2860

Q24201474-3F8BDB26-AAAA-4D10-A6D7-6339431FCFD6 Q26801433-E53CCFFB-2AC8-418F-B21D-651B1E3EE270 Q30377539-5E9194D9-7FAC-4BB1-8E88-086C1B84905D Q30425495-6BA8A807-3143-4847-9648-D61ADF92F258 Q31159585-AC08A794-68B5-4B5C-A482-7352E5D02BB7 Q33407272-53E95222-C1EB-4564-A2C6-555EE61583EB Q33414170-A37E0473-2223-46B6-9276-AAE5D57DC518 Q33525198-E4987BE6-79CF-41F3-8D2B-075B2010EE9F Q33641227-B8751BC6-EBB0-4343-A885-1B2C9186B120 Q33801302-937A20F2-79EE-40BF-B12F-2743B1DEB0B2 Q33810591-7856B5AB-54ED-43A4-8DFA-34178B52E2D1 Q34185432-F67C245B-62F0-477A-B8F9-F94AF35D87D8 Q34204883-78680391-48E0-4C1A-961E-D7DF872833FF Q34516669-0D416720-F222-4C6C-B504-B0E4CE8C2448 Q35040832-56104E11-D0DB-4A81-81DD-1BFC5B41466D Q35611826-408AC853-03BE-49AB-82BE-0EC8FAE7D1F8 Q36714699-61DA866A-90C2-49C3-B4F9-EDE7C1E1BA35 Q36909916-9157950C-9254-498E-9F45-1DACC2714D8C Q37248663-5ABF31F5-700C-4A55-8B72-3C7D567884F9 Q37597588-8E66991C-F92A-44C6-8EA6-B009D14763AB Q37709623-479D6899-F6D0-4D99-8749-B180B7A5CB46 Q38082673-B0BD66B0-FE02-474B-A7DE-9F4F0402226D Q38253988-B8521A9C-CDD9-4B20-BCDB-99BF45BCC9FF Q41086653-3A1B91C8-3DE5-4951-A38A-FB9E6F5D6C1E Q46042350-F06DF5B6-4F5D-41B3-B4B1-A228B5B09FF0 Q46102542-7AE0DD5E-8328-44E6-ABD6-B3226BCBC5BE Q48563045-8C7260DD-A61D-4EBF-94D6-A08555E29BCE Q51774517-03FDCBBF-072C-4B4E-8B44-5C4CDE29E5F4

P2860

Pneumococcal vaccination and risk of myocardial infarction.

http://www.wikidata.org/entity/Q36909937

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Pneumococcal vaccination and risk of myocardial infarction.

@en

type

label

Pneumococcal vaccination and risk of myocardial infarction.

@en

prefLabel

Pneumococcal vaccination and risk of myocardial infarction.

@en

P1433

Q36909937-1BF7358C-42E8-4A92-9833-D0BDCA0903B9

P1476

Q36909937-8B268C6B-AFD2-4EA8-80E9-EE467D9270E8

P2093

Q36909937-17863E84-1F2E-4DAE-8AB5-E39FDC107E29

Q36909937-575C6C38-8192-4F9C-A98F-AB59BD435E8B

Q36909937-C1BADA35-C682-4A33-A076-23C5757F11A6

Q36909937-CB5A288F-D2A6-424E-9272-40258414619E

Q36909937-D8091375-A38C-4A62-A1C0-17BD86F62A66

Q36909937-EA83EBA9-929C-41E7-A2D2-2DC2A60DC1B4

P2860

Q36909937-13C27A3B-201E-47C0-92F6-1EBFF8174405

Q36909937-14D84513-1FCD-48FA-960B-E2B156E79A58

Q36909937-1BB88E80-F014-472A-9EEE-FEEFE9D705CE

Q36909937-2138A497-1BD5-4292-9127-4087A08A3F20

Q36909937-25A19402-59D9-42B0-8DAA-8091385ECEB0

Q36909937-33632B1F-837B-41EF-9B34-5CDB34F99AA0

Q36909937-589A7DDD-223A-40F2-BD86-FC6CB7415276

Q36909937-5E83CB75-86BE-451D-951F-B468EFE21742

Q36909937-809F3695-CBA9-444A-994A-5637AB11BDA1

Q36909937-8564B128-0FEB-4EA8-8C40-B7A7FD2D04A5

P304

Q36909937-7201EB76-CADF-49D1-A7BA-14D1475BF1A3

P31

Q36909937-392674F7-51E8-4A89-B991-F515D2A00F22

P356

Q36909937-FF353F4C-CA31-42EB-AE75-C4F0D2CC2DF5

P407

Q36909937-A4643580-F9C8-411B-817A-37183A32590C

P433

Q36909937-788C8E2B-8BDB-49B2-9D15-87965C667D72

P478

Q36909937-0EEFD076-24F4-4074-9C0B-DBB9515FAD3D

P577

Q36909937-261585EE-023D-4CE4-9A32-0374DDC880DD

P5875

Q36909937-6B6A034C-1D80-4058-B0B2-ED52C5072EB8

P698

Q36909937-72A9E938-7F0A-41E2-B3E5-810B159BF4E1

P932

Q36909937-BF705C0B-4C38-49FD-8B77-E655BB21F932

P356

P1433

Canadian Medical Association Journal

P1476

Pneumococcal vaccination and risk of myocardial infarction.

@en

P2093

Danielle Pilon

http://www.w3.org/2001/XMLSchema#string

François Lamontagne

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Carvalho

http://www.w3.org/2001/XMLSchema#string

Luc Lanthier

http://www.w3.org/2001/XMLSchema#string

Marek Smieja

http://www.w3.org/2001/XMLSchema#string

Marie-Pierre Garant

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation, atherosclerosis, and coronary artery disease

Integrating feedback from a clinical data warehouse into practice organisation.

Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.

Novel risk factors for atherosclerosis.

Splenectomy and subsequent mortality in veterans of the 1939-45 war.

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.

Azithromycin for the secondary prevention of coronary events.

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.

P304

773-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.070221

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23302910

http://www.w3.org/2001/XMLSchema#string

P698

18838452

http://www.w3.org/2001/XMLSchema#string

P932

2553874

http://www.w3.org/2001/XMLSchema#string